EGFR Mutation Status in NSCLC Patients Stage IIIB/IV in Germany – Initial Results from a German Registry. 1. Juni 2011 Thomas, M., Eberhardt, W., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Gutendorf, B., Zirrgiebel, U., Schütte, W., 2011. EMCC / ESMO, European Multidisciplinary Cancer Congress, Stockholm (Abstract 9015), 596. The treatment of lung cancer in German outpatient centres. Data from a clinical registry – TLK Registry. Tessen, H.W., Hutzschenreuter, U., Steffens, C.C., Nusch, A., Spirik, J., Marschner, N., 2011. Onkologie 34 (suppl 6)(P533), 153. doi:10.1159/000333301 Abstract… Weiterlesen REASON: TKI sensitive EGFR mutation status and associated characteristics of advanced NSCLC patients – Results from a German registry. Thomas, M., Eberhardt, W., Graf von der Schluenburg, J., Dietel, M., Schirmacher, P., Gutendirf, B., Schaller, F., Schütte, W., 2011. Onkologie 34 (suppl 6)(V451), 124. Weiterlesen